Intelligence · Clinical Development
Pipeline search results
Programs matching “modified” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 12 pipeline programs matching "modified" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
DC 06/02
Takeda
Adrenal Insufficiency
1 trial -
Hydrocortisone Modified Release Capsules
NEUROCRINE BIOSCIENCES INC
Endocrine Disease
1 trial -
Modified Wenxin Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Heart Failure
1 trial -
Modified-Release Prednisone
United Therapeutics Europe Ltd
Chronic Inflammation
1 trial -
Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-induced Oral Mucositis
1 trial -
VEN+AZA+Modified BUCY
The First People's Hospital of Lianyungang
Allogeneic Hematopoietic Stem Cell Transplantation
2 trials -
KVD824 Prototype 1 modified-release tablet
Kalvista Pharmaceuticals (Ireland) Limited
Hereditary Angioedema
1 trial -
Modified Gegen Qinlian Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial -
ZFN modified T cells
SANGAMO THERAPEUTICS, INC
HIV
1 trial -
Qingre Huashi Granules combined the modified dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
modified BEAM
The First People's Hospital of Lianyungang
Autologous Stem Cell Transplantation
1 trial -
modified Ma Xing Shi Gan Decoction
Universal Integrated
Chronic Obstructive Pulmonary Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.